Evidence map›Paper›PMID 32368503›Full record

ArticleToxicology reports2020

Phthalate metabolites concentrations in amniotic fluid and maternal urine: Cumulative exposure and risk assessment.

Ioanna Katsikantami, Manolis N Tzatzarakis, Athanasios K Alegakis, Vasiliki Karzi, Eleftheria Hatzidaki, Athina Stavroulaki, Elena Vakonaki, Pelagia Xezonaki, Stavros Sifakis, Apostolos K Rizos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Placental Pathophysiology and Developmental Programming of Adult Cardiometabolic Risk: A Narrative Review of Pregnancy Exposures.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Ioanna KatsikantamiDepartment of Chemistry, University of Crete & Foundation for Research and Technology-Hellas (FORTH-IESL), 71003, Heraklion, Crete, Greece.
Manolis N TzatzarakisLaboratory of Toxicology Science and Research, Medical School, University of Crete, 71003, Heraklion, Crete, Greece.
Athanasios K AlegakisLaboratory of Toxicology Science and Research, Medical School, University of Crete, 71003, Heraklion, Crete, Greece.
Vasiliki KarziDepartment of Chemistry, University of Crete & Foundation for Research and Technology-Hellas (FORTH-IESL), 71003, Heraklion, Crete, Greece.
Eleftheria HatzidakiDepartment of Neonatology & NICU, University Hospital of Heraklion, Crete, Greece.
Athina StavroulakiDepartment of Chemistry, University of Crete & Foundation for Research and Technology-Hellas (FORTH-IESL), 71003, Heraklion, Crete, Greece.
Elena VakonakiLaboratory of Toxicology Science and Research, Medical School, University of Crete, 71003, Heraklion, Crete, Greece.
Pelagia XezonakiMitera, Maternity Hospital, Heraklion, Crete, Greece.
Stavros SifakisMitera, Maternity Hospital, Heraklion, Crete, Greece.
Apostolos K RizosDepartment of Chemistry, University of Crete & Foundation for Research and Technology-Hellas (FORTH-IESL), 71003, Heraklion, Crete, Greece.
Aristidis M TsatsakisLaboratory of Toxicology Science and Research, Medical School, University of Crete, 71003, Heraklion, Crete, Greece.
University of Crete · GRFoundation for Research and Technology Hellas · GRMitera Hospital · GRUniversity Hospital of Heraklion · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phthalates are used in industry as plasticizers or additives in everyday products and they have been considered as endocrine disrupting chemicals. Maternal exposure during pregnancy has been associated with neonatal exposure, preterm birth and impacts in the reproductive and respiratory systems. The aim of this study is to determine six phthalate metabolites (mono isobutyl phthalate, miBP, mono n-butyl phthalate, mnBP, mono benzyl phthalate, mBzP, mono ethylhexyl phthalate, mEHP, mono 2-ethyl-5-hydroxyhexyl phthalate, mEHHP, mono 2-ethyl-5-oxohexyl-phthalate, mEOHP) in amniotic fluid and urine from 100 pregnant women. Participants answered questionnaires for the use of plastics and cosmetics, dietary habits, health effects, pregnancy problems, health and infant development. Positive amniotic fluid samples ranged from 1% to 21% and urine from 27% to 54%. The median levels for amniotic fluid were 2.3 μg/L - 10.7 μg/L and for urine 4.9 μg/L - 46.7 μg/L. The major results include significant correlations between urinary phthalates indicating their common sources of exposure, the frequent use of deodorant was significantly associated with higher urinary miBP (p = 0.050) and mnBP (p = 0.028) and a weak inverse association was found for the use of make-up products with mBzP (p = 0.053). The frequent use of plastic food containers was significantly associated with urinary mEHP (p = 0.026), and a positive trend was noticed for mEHP in amniotic fluid (p = 0.093). An association although weak was found between urinary mEHP and lower birth length (rs = 0.396, p = 0.062). No other associations were found for infant health problems or development. The daily intake of the total phthalates was calculated 5.4 μg/kg body weight/day which corresponds to hazard index 0.10 and exposure follows the declining trend that has been observed the last decades.

Indexed as

2cx-mMHP, mono 2-carboxymethyl-hexyl phthalateAmniotic fluidBBzP, benzyl butyl phthalateDaily intakeDEHP, di 2-ethylhexyl phthalateDiBP, di iso-butyl phthalateDiNP, di isononyl phthalateDnBP, di n-butyl phthalateEDCs, endocrine disrupting chemicalsEDI, estimated daily intake HQ, hazard quotientHI, hazard indexLC-APCI-MS, liquid chromatography-atmospheric pressure chemical ionization-mass spectrometrymBzP, mono benzyl phthalatemECPP or 5cx-mEPP, mono 2-ethyl-5-carboxypentyl phthalatemEHHP or 5OH-mEHP, mono 2-ethyl-5-hydroxyhexyl phthalatemEHP, mono ethylhexyl phthalatemEOHP or 5oxo-mEHP, mono 2-ethyl-5-oxohexyl-phthalatemEP, mono ethyl phthalatemiBP, mono iso-butyl phthalatemmP, mono methyl phthalatemnBP, mono n-butyl phthalatePhthalate metabolitesRisk assessmentUrine

Identifiers

PMID32368503
PMCPMC7186561
OpenAlexW3017371656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.